Diffuse alveolar hemorrhage is encountered uncommonly, but it is useful to have a general understanding of this. Many etiologies can cause diffuse alveolar hemorrhage, with pulmonary vasculitis being perhaps the most widely feared. This chapter explores how to sift through the differential diagnosis of diffuse alveolar hemorrhage and, if vasculitis is suspected, how to initiate therapy for this.
🚨 #PexivasPolice 🚨 will fine you
— Matthew Sparks, MD, FASN, FAHA (@Nephro_Sparks) April 11, 2019
This chapter may also serve as a public protest for the ridiculous amount of time that it's taking the PEXIVAS trial to reach press. The abstract was released nearly a year ago. This might stir up the ire of the Pexivas Police (see above), but seriously… if there is a journal out there somewhere sitting on this study – please publish it already. Or just release a preliminary version electronically. Excessive publications delays are unethical as this impairs patient care.
The IBCC chapter is located here.
- The podcast & comments are below.
Follow us on iTunes
The Podcast Episode
Want to Download the Episode?
Right Click Here and Choose Save-As
- IBCC chapter – Disseminated Intravascular Coagulation (DIC) - January 18, 2021
- PulmCrit- RCTs don't justify using convalescent plasma or antibody cocktails - January 14, 2021
- PulmCrit – Six RCTs to answer one question: what is the role of tocilizumab in COVID-19? - January 12, 2021